Keystone Financial Group (Kentucky)’s BioRestorative Therapies BRTX Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio BRTX Stock Details BRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8K	Buy	+1,430	New	+$8.37K	﹤0.01%	564

Other funds holding BRTX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s BRTX Position: Q2 2026 in Review

Keystone Financial Group (Kentucky) opened a new position in BioRestorative Therapies (BRTX) in Q2 2026: 1,430 shares worth $10.8K. The stake represents ﹤0.01% of the portfolio and ranks #564 among its holdings.

18 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

Keystone Financial Group (Kentucky) held 1,430 shares of BioRestorative Therapies worth $10.8K as of Q2 2026.
BioRestorative Therapies was a new Keystone Financial Group (Kentucky) position in Q2 2026.
BioRestorative Therapies made up ﹤0.01% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #564 holding.
18 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.